Tackling the threat of AMR

The ups and downs of ADCs – where to now?

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025

Stronger together: changing the future of muscle wasting condition

How bioengineered spider silk-based proteins are changing the world

How to have a perfect IPO on NASDAQ

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

How AI is revolutionising drug research

Curve Therapeutics – Addressing challenging drug targets

Biotech IPOs make a comeback in 2024

Anglonordic Life Science Conference strikes optimistic note for ‘24

The challenges of recruitment for clinical trials

Lytix Biopharma – Innovations in Killing Cancer